{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-034091","form_type":"8-K","ticker":"INBP","cik":"0001016504","company_name":"INTEGRATED BIOPHARMA INC","filed_at":"2025-11-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.544175+00:00","generated_at":"2026-05-16T22:11:34.135457+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Integrated BioPharma Q1 revenue down 6.6% to $12.7M; net income $0.1M, EPS $0.00","bullets":["Revenue $12.7M, down 6.6% from $13.6M YoY; gross profit $1.0M vs $1.4M.","Net income $123K ($0.00 basic EPS) vs $259K ($0.01) in prior year quarter.","Operating income $163K vs $490K YoY, driven by lower gross profit.","Two largest customers in Contract Manufacturing = 87% of total revenue (85% in prior year)."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-034091","json":"https://secwatch.observer/filing/0001437749-25-034091.json","markdown":"https://secwatch.observer/filing/0001437749-25-034091.md","text":"https://secwatch.observer/filing/0001437749-25-034091.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1016504/000143774925034091/0001437749-25-034091-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1016504/000143774925034091/inbp20251107_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T22:11:34.135457+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}